The BCL2L11 (BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients. (1st November 2012)

Record Type:: Journal Article
Title:: The BCL2L11 (BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients. (1st November 2012)
Main Title:: The BCL2L11 (BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients
Authors:: Katagiri, Seiichiro
Umezu, Tomohiro
Ohyashiki, Junko H.
Ohyashiki, Kazuma
Abstract:
Is Part Of:: British journal of haematology. Volume 160:Number 2(2013:Jan.)
Journal:: British journal of haematology
Issue:: Volume 160:Number 2(2013:Jan.)
Issue Display:: Volume 160, Issue 2 (2013)
Year:: 2013
Volume:: 160
Issue:: 2
Issue Sort Value:: 2013-0160-0002-0000
Page Start:: 269
Page End:: 271
Publication Date:: 2012-11-01
Subjects:: Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.12111 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 3801.xml